Sage for Hot Flashes: Extract Trials, Dose Labels and Their Limits

A claim that sage reduced hot flashes needs a few details beside it: the product tested, whether there was a placebo group, and whether the number describes daily flashes or a symptom score. The studies give different answers to those questions.

The early study had no comparison group

The 2011 Swiss study¹ recruited 71 women, with 69 included in its treatment analysis. Participants took a fresh-sage extract tablet daily for eight weeks. Mean daily hot flashes fell from 9.3 to 3.8.¹

The frequently quoted 64% reduction concerned an intensity-weighted hot-flash score, rather than a 64% reduction in the number of daily flashes. Neither figure was adjusted for improvement with placebo: the study had no placebo or untreated group. Natural fluctuation, expectations and other changes could contribute.¹

A.Vogel Bioforce sponsored the study, and two authors held senior roles at the company. One participant had mild abdominal pain and diarrhea judged related to treatment. This was useful preliminary research, with considerable uncertainty about how much improvement sage itself produced.¹

The 2021 placebo trial focused on a selected subgroup

The German trial enrolled 80 postmenopausal women aged 48–65 and tested four weeks. Its main analysis used 48 women aged 48–56, excluding older participants by design.²

In that subgroup, the sage group’s hot-flash severity score fell 55.3%, versus about 27% with placebo. This combined frequency and intensity; it was not a count of women cured. Broader analyses also favored sage.²

The product contained 280 mg of thujone-free extract, described as equivalent to 3,400 mg of tincture. That larger figure does not mean 3,400 mg of dried leaves. A.Vogel funded the study and employed one author. Four weeks cannot establish safety over years.²

The longer Iranian trial used another preparation

Published in 2020, the Shiraz study assigned 66 postmenopausal women to sage or placebo for 12 weeks. It used Gol Daroo tablets containing 100 mg extract, taken three times daily. Fifty-nine participants completed; seven were excluded for incomplete pill use.³

The investigators reported no significant differences between groups in hot-flash frequency or severity at weeks 2, 4, 6 or 8, with differences appearing at weeks 10 and 12. The finding argues against promising an immediate response.³

The small study relied on symptom records and questionnaires, and excluding nonadherent participants can bias the comparison. Its extract and schedule differed from the branded German trial. The milligram numbers alone do not establish an equivalent dose.³

Tea, essential oil and extract tablets need separate evidence

These three studies tested tablets. None tested brewing leaves in a mug or swallowing essential oil. Their results cannot supply a tea recipe, an essential-oil dose or a conversion between products.¹²³

Before buying, check the label for the botanical name, the preparation, the amount per tablet and the number of tablets per serving. Photograph the ingredients panel as well as the front label. “Sage 100 mg” leaves questions about what was extracted and how that preparation compares with a study product.

NCCIH, the US complementary-health research centre, concludes that a few small studies suggest common sage may reduce hot-flash frequency, while the overall research remains limited. It distinguishes ordinary food amounts from larger or prolonged doses: common sage can contain thujone, which can be toxic in high amounts.⁴

The agency warns that medicinal use may be unsafe during pregnancy, that breastfeeding safety is poorly understood, and that people taking medicines should discuss herbal products with their healthcare provider. A thujone-free label does not answer every safety or interaction question.⁴

Put the possible benefit beside established options

The Menopause Society’s 2023 nonhormone position statement places supplements and herbal remedies in its not-recommended category for hot flashes. That is a recommendation about the available evidence, rather than a claim that every small trial was negative.⁵

The statement recommends options including menopause-focused cognitive behavioural therapy, clinical hypnosis and several prescription treatments. Ask which are suitable for your symptoms and medical history before spending months testing supplements.⁵

In the United States, dietary supplements do not receive FDA approval before sale. A product being available on a pharmacy shelf does not establish that it has demonstrated efficacy for hot flashes.⁴

Bring a symptom record and the product label

The “Try It” section of the heat chapter in My Body Changed. Now What? recommends recording hot-flash frequency, night waking and how much symptoms bother you, while identifying the change being tried and its start date.

Bring those notes and the full label to an appointment. Ask what improvement would justify continuing, when to review it and which adverse effects should prompt stopping. If sleep and daily activities remain disrupted, say so directly. The goal of that conversation is a workable treatment plan, with enough information to judge whether it is helping.